At the 2022 ACHEMA conference we had the pleasure of getting to talk to Slim Chiha, CEO and founder of Prosion Therapeutics who was participating in the Start-Up Challenge Award.
PROSION is a Biotech and drug development company based in Germany that aims at making the undruggable druggable. Through a proprietary platform technology of LEGO-like chemical building blocks, they are able to develop new and effective drugs, targeting hard-to-treat diseases - starting with the most aggressive cancer forms.
Hear what Slim has to say about:
- How he came to be working with Prosion
- The challenges of scaling up drug candidates
- The biggest development he's seen in the industry so far
About Slim Chiha
Slim has a Ph.D. in Chemistry and a special interest in drug development. He co-founded and is CEO of a biotech startup that holds the Seal of Excellence of the European Commission. Previously he has experience as a medicinal chemist in a publicly funded oncology project and trained at a global pharmaceutical company.
